This year also saw the Ministry taking the decision of introducing new vaccines as part of India's Universal Immunisation Programme (UIP) in its bid to protect children from more vaccine preventable diseases and it will done in a phased manner.
The nationwide drug resistance survey was also launched with an aim to provide the Revised National TB Control Programme with a better estimate on the burden of multi-drug resistant tuberculosis in the community.
The ministry's plan to implement larger pictorial warnings ran into rough weather early this year when it had to indefinitely delay the matter pending the decision of a parliamentary committee which was examining the issue.
The committee was looking into the contentious issue of amendment to the Cigarettes and Other Tobacco Products (Packaging and Labelling) Rules, 2008, to increase the size of the warnings from the current 40 per cent to 85 per cent.
The Rajasthan High Court on September 9 ordered the Centre to ensure that larger pictorial warnings are carried on all tobacco products by September 29. This forced the ministry to hurriedly come out with a notification just a day before a hearing on the matter saying all tobacco products will carry warnings covering 85 per cent of the package area from April 1, 2016, up from 40 per cent at present.
Till now, through two rounds conducted by the ministry,
189.2 lakh antigens have been administrated under 94 lakh sessions while as many as 75.5 lakh children have been immunised and almost 20 lakh children are fully immunised.
The ministry said that more than 20 lakh women are vaccinated and 11 lakh are fully immunised.
The first National De-worming Day was also observed in February. Touted as a major initiative, it was implemented in 277 districts covering 11 states and UTs across 4.7 lakh schools and 3.67 lakh anganwadi centers.
While the ministry has already launched the Inactivated Polio Vaccine which will benefit 2.7 crore children every year, it also taken the decision to introduce Adult Japanese Encephalitis (JE) vaccine in 20 high burden districts which have been identified in Assam, Uttar Pradesh and West Bengal.
The Ministry also decided to introduce a Rotavirus vaccine as rotavirus is the leading cause of severe diarrhoea among infants and young children. Each year, approximately 2 lakh children in India die due to diarrhoea of which around 1 lakh deaths are caused by Rotavirus.
This is in addition to the six new AIIMS at Raipur, Bhopal, Patna, Bhubaneshwar, Rishikesh and Jodhpur where the ministry claimed that hospital work has begun for the last one year and high-end clinical care is being provided besides the MBBS teaching activities.
As far as these nine new AIIMS are concerned, the ministry kept itself busy in completing pre-investment activities for AIIMS at Andhra Pradesh, West Bengal and Maharashtra while site inspection was completed completed in Assam and Tamil Nadu. The process will be completed soon for Uttar Pradesh, Punjab and Himachal Pradesh, it claimed.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
